Morphological and functional effects of antisense RNA to the deleted in colorectal carcinoma (DCC) gene in a pancreatic carcinoma cell line

Cancer Letters

Volumn 145, Issue 1-2, 1999, Pages 9-15

  Pohl, Ute ^a   Höhne, Martin W ^a   Gerlich, Wolfram H ^a   Schaefer, Stephan ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Antisense RNA; Cell adhesion; Deleted in colorectal carcinoma gene; MiaPaCa 2; Pancreatic tumours; Tumour suppressor

Indexed keywords

COMPLEMENTARY RNA;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL CYCLE S PHASE; COLORECTAL CARCINOMA; GENE DELETION; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; PANCREAS CARCINOMA; PRIORITY JOURNAL;

CARCINOMA, DUCTAL, BREAST; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; COLORECTAL NEOPLASMS; CYTOSKELETON; GENE DELETION; HUMANS; PANCREATIC NEOPLASMS; RNA, ANTISENSE;

EID: 0345034818     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00204-9     Document Type: Article

References (20)

1. Bennett K.L., Bradshaw J., Youngman T., Rodgers J., Greenfield B., Aruffo A., Linsley P.S. Deleted in colorectal carcinoma (DCC) binds heparin via its fifth fibronectin type III domain. J. Biol. Chem. 272:1997;26940-26946.
2. Boschek C.B., Jockusch B.M., Friis R.R., Back R., Grundmann E., Bauer H. Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell. 24:1981;175-184.
3. Cho K.R., Oliner J.D., Simons J.W., Hedrick L., Fearon E.R., Preisinger A.C., Hedge P., Silverman G.A., Vogelstein B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics. 19:1994;525-531.
4. Chuong C.M., Jiang T.X., Yin E., Widelitz R.B. cDcc (chicken homologue to a gene deleted in colorectal carcinoma) is an epithelial adhesion molecule expressed in the basal cells and involved in epithelial-mesenchymal interaction. Dev. Biol. 164:1994;383-397.
5. Fazeli A., Dickinson S.L., Hermiston M.L., Tighe R.V., Steen R.G., Smll C.G., Stoeckli E.T., Keino-Masu K., Masu M., Rayburn H., Simons J., Bronson R.T., Gordon J.I., Tessier-Lavigne M., Weinberg R.A. Phenotype of mice lacking functional Deleted in colorectal carcinoma (DCC) gene. Nature. 386:1997;796-804.
6. Fearon E.R. is there a connection between tumorigenesis and cell guidance molecules? Biochim. Biophys. Acta. 1288:1996;M17-M23.
7. Fearon E.R., Cho K.R., Nigro J.M., Kern S.E., Simons J.W., Ruppert J.M., Hamilton S.R., Preisinger A.C., Thomas G., Kinzler K.W., et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 247:1990;49-56.
8. Guadagno T.M., Ohtsubo M., Roberts J.M., Assoian R.K. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science. 262:1993;1572-1575.
9. Hedrick L., Cho K.R., Boyd J., Risinger J., Vogelstein B. DCC: a tumor suppressor gene expressed on the cell surface. Cold Spring Harbor Symp. Quant. Biol. 57:1992;345-351.
10. Höhne M.W., Halatsch M.E., Kahl G.F., Weinel R.J. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 52:1992;2616-2619.
11. Keino-Masu K., Masu M., Hinck L., Leonardo E.D., Chan S.S.-Y, Culotti J.G., Tessier-Lavigne M. Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell. 87:1996;175-185.
12. Mehlen P., Rabizadeh S., Snipas S.J., Assa-Munt N., Salvesen G.S., Bredesen D.E. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 395:1998;801.
13. Narayanan R., Lawlor K.G., Schaapveld R.Q., Cho K.R., Vogelstein B., Bui P. Vinh Tran. M.P. Osborne, N.T. Telang, Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts, Oncogene. 7:1992;553-561.
14. Reale M.A., Reyes-Mugica M., Pierceall W.E., Rubinstein M.C., Cohn S.L., Nakagawara A., Brodeur G.M., Fearon E.R. Loss of DCC expression in neuroblastoma is associated with disease dissemination. Clin. Cancer Res. 2:1996;1097-1102.
15. Rieger-Christ K., Brierley K., Reale M. The DCC protein - neural development and the malignant process. Front. Biosci. 2:1997;D438-D448.
16. Rogne S., Ronning O.W., Myklebost O., Seglen P.O., Pettersen E.O. Cell cycle traverse and protein metabolism in human NHIK 3025 cells: the role of anchorage. J. Cell Physiol. 125:1985;528-532.
17. Stein G.S., Stein J.L., Lian J.B., Last T.J., Owen T., McCabe L. Cell synchronization as a basis for investigating control of proliferation in mammalian cells. Studzinski G.P. Cell Growth and Apoptosis. A Practical Approach. vol. 159:1995;193-203 Oxford University Press, Oxford.
18. Turley H., Pezzella F., Kocialkowski S., Comley M., Kaklamanis L., Fawcett J., Simmons D., Harris A.L., Gatter K.C. The distribution of the deleted in colon cancer (DCC) protein in human tissues. Cancer Res. 55:1995;5628-5631.
19. White R.L. Tumor suppressing pathways. Cell. 92:1998;591-592.
20. Yoshida Y., Itoh F., Endo T., Hinoda Y., Imai K. Decreased DCC mRNA expression in human gastric cancers is clinicopathologically significant. Int. J. Cancer. 79:1998;634-639.